{"id":129,"date":"2020-04-30T04:39:49","date_gmt":"2020-04-30T04:39:49","guid":{"rendered":"https:\/\/nclinnovations.org\/covid19monitor\/?p=129"},"modified":"2020-04-30T04:39:49","modified_gmt":"2020-04-30T04:39:49","slug":"29-april-2020-remdesivir-results-from-interim-analysis-show-31-faster-time-to-recovery","status":"publish","type":"post","link":"https:\/\/nclinnovations.org\/covid19monitor\/29-april-2020-remdesivir-results-from-interim-analysis-show-31-faster-time-to-recovery\/","title":{"rendered":"(29 April 2020) Remdesivir- Results from interim analysis show 31% faster time to recovery"},"content":{"rendered":"<div class=\"boldgrid-section\">\n<div class=\"container\">\n<div class=\"row\">\n<div class=\"col-md-12 col-xs-12 col-sm-12\">\n<p id=\"main-content\" class=\"block--content-card__title\">NIH Clinical Trial Shows Remdesivir Accelerates Recovery from Advanced COVID-19<\/p>\n<p class=\"\">https:\/\/www.niaid.nih.gov\/news-events\/nih-clinical-trial-shows-remdesivir-accelerates-recovery-advanced-covid-19<\/p>\n<p class=\"\">The interim analysis of results from the trial (known as the <a id=\"anch_349\" href=\"https:\/\/www.niaid.nih.gov\/news-events\/nih-clinical-trial-remdesivir-treat-covid-19-begins\" data-content=\"body-anchor-adaptive-covid-19-treatment-trial\">Adaptive COVID-19 Treatment Trial<\/a>, or ACTT), sponsored by the&nbsp;&nbsp; National Institute of Allergy and Infectious Diseases (NIAID) suggest that remdesivir had a 31% faster time to recovery than those who received placebo (p&lt;0.001). Specifically, the median time to recovery was 11 days for patients treated with remdesivir compared with 15 days for those who received placebo. Results also suggested a survival benefit, with a mortality rate of 8.0% for the group receiving remdesivir versus 11.6% for the placebo group (p=0.059).&nbsp;<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>NIH Clinical Trial Shows Remdesivir Accelerates Recovery from Advanced COVID-19 https:\/\/www.niaid.nih.gov\/news-events\/nih-clinical-trial-shows-remdesivir-accelerates-recovery-advanced-covid-19 The interim analysis of results from the trial (known as the Adaptive COVID-19 Treatment Trial, or ACTT), sponsored by the&nbsp;&nbsp; National Institute of Allergy and Infectious Diseases (NIAID) suggest&hellip; <span class=\"read-more-span\"><a href=\"https:\/\/nclinnovations.org\/covid19monitor\/29-april-2020-remdesivir-results-from-interim-analysis-show-31-faster-time-to-recovery\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;(29 April 2020) Remdesivir- Results from interim analysis show 31% faster time to recovery&#8221;<\/span> <span class=\"genericon genericon-next\"><\/span><\/a><\/span><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"bgseo_title":"","bgseo_description":"","bgseo_robots_index":"index","bgseo_robots_follow":"follow"},"categories":[6,4,5],"tags":[25],"_links":{"self":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/129"}],"collection":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/comments?post=129"}],"version-history":[{"count":1,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/129\/revisions"}],"predecessor-version":[{"id":131,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/129\/revisions\/131"}],"wp:attachment":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/media?parent=129"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/categories?post=129"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/tags?post=129"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}